Acquisition

06th October, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition of 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli)– Reg. Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of Krishna Institute of Medical Sciences Limited (“the Company”) at its meeting held on today, i.e. 06th October, 2026 has approved the proposal for acquisition 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli), an O & M entity. We enclose herewith the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as an Annexure-1 to this letter. Kindly take the above intimation on your records. This intimation is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary and Compliance Officer ANNEXURE -1 a Name of the target entity, details in brief Name of the target entity: Ushahkal Abhinav such as size, turnover, etc., Specialty Hospital LLP. Details in brief: Ushahkal Abhinav Speciality Hospital LLP, (UAIMS) incorporated under the laws of India with its registered office at C. S. No. 105/1, Near Takshila School, Dhamani Road, Sangli – 416416 (Maharashtra), founded in 2022, is a state-of-the-art quaternary care facility with a current capacity of 316 beds and potential for expansion to over 500 beds. Spanning 4 acres, it boasts one of the highest floor-area-to-bed ratios in the region. To enhance UAIMS operational efficiency, the KIMS has partnered with UAIMS to exclusively manage and operate the hospital, providing high-quality medical services under the “KIMS-UAIMS” brand. KIMS will assume full responsibility for the hospital's management, ensuring smooth and effective operations. (Rs. in Crore) FY 2025-26 Turnover: 80.42 PAT: -23.59 Networth: 116.42 b Whether the acquisition would fall within The Transaction does not fall under a related party related party transaction(s) and whether transaction. the promoter / promoter group / group companies have any interest in the entity being acquired? If yes, nature of Interest and details thereof and whether the same is done at "Arms length": c Industry to which the entity being acquired Healthcare Industry belongs: d Objects and effects of acquisition (including KIMS being the O & M Partner of the target entity but not limited to, disclosure of reasons for has decided to acquire 6% of the total stake as a acquisition of target entity, if its business is strategic investment. outside the main line of business of the listed entity e Brief details of any governmental or regulatory Not Applicable. approvals required for the acquisition: f Indicative time period for completion of the On or before 31-10-2026 acquisition g Consideration - whether cash consideration Cash. or share swap and details of the same: h Cost of acquisition or the price at which the The acquisition is based on the valuation report shares are acquired; issued by BDO Valuation Advisory LLP, dated 05th October, 2026, for an aggregate consideration up to ₹15 Crore (Rupees Fifteen Crore only) by way of primary infusion, for 6% stake of the target LLP. i Percentage of shareholding/control KIMS will acquire 6% of the stake of Target LLP, acquired and/or number of shares for an aggregate consideration of ₹15 Crore acquired; (Rupees Fifteen Crore only) by way of primary infusion. j Brief background about the entity acquired Brief background about the entity acquired: As in terms of products/line of business mentioned in serial no. (a) acquired, date of incorporation, history of Date of Incorporation of LLP: 25-11-2016 last 3 years turnover, country in which the acquired entity has presence, and any other History of last 3 years Total Turnover of the significant information (in brief): Company: Particulars Amount in Crores FY26 80.42 FY25 73.55 FY24 64.51 Presence: Sangli, Maharashtra - India Other Significant Information: please refer to the aforementioned.